2025-08-13 13:30:23 ET

Longeveron Jumps 32% on $17.5M Public Offering to Advance Stem Cell Therapy
Longeveron Inc. ( LGVN ) climbed 31.61% to lead the PRISM Emerging Global Health Index after closing a public offering of up to $17.5 million in gross proceeds . The deal included $5 million upfront through the sale of Class A common stock and short-term warrants, with the potential for an additional $12.5 million if all warrants are exercised. Proceeds will fund clinical and regulatory development of the company's allogeneic mesenchymal stem cell therapy, laromestrocel (Lomecel-B(TM)), targeting conditions such as hypoplastic left heart syndrome, Alzheimer's disease, pediatric dilated cardiomyopathy, and aging-related frailty. Multiple FDA designations, including Orphan Drug and RMAT, underscore the therapy's potential across a range of indications.

Tilray Brands Gains 17% on U.S. Cannabis Reclassification Hopes
Tilray Brands, Inc. ( TLRY ) continues its climb this week rising 16.78% today, boosting the PRISM Emerging Cannabis Index , following a Wall St. Journal report that President Donald Trump indicated his administration is considering reclassifying cannabis as a less dangerous substance . The announcement, which could come in the next few weeks, sent cannabis stocks sharply higher this week. Investors see reclassification as a major catalyst for industry growth, reducing legal and banking hurdles while broadening institutional participation.

Other PRISM Mid-Day Movers:
? Bit Digital, Inc. ( BTCM ) up 28.18%
? 180 Life Sciences Corp. ( ATNF ) up 24.64%
? electroCore, Inc. ( ECOR ) gained 22.87%

The post PRISM Mid-Day Movers: Regenerative Medicine Financing and Cannabis Policy Momentum Boost Indices appeared first on PRISM MarketView .

COMTEX_468015333/2927/2025-08-13T12:30:23